Please assess the completion status of the following clinical trial:

Trial Title: Generation of an Induced Pluripotent Stem (iPS) Cell Bank Immune Matched to a Majority of the US Population

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Be associated with an NMDP/Be The Match-operated donor center or non-operated donor center that has an IRB Authorization Agreement with the NMDP IRB and allows NMDP staff to directly contact their donors~2. Possess an HLA haplotype of interest to the Study~3. Be at least 18 years of age and not past 61st birthday~4. Meet the following criteria and requirements:~4.1 Meet the donor requirements under 21 CFR 1271 and related August 2007 guidance 4.2 Body weight of at least 110 pounds 4.3 Complete and pass the abbreviated Health History Screening questionnaire 4.4 Complete and pass the full Health History questionnaire after donor enrollment 4.5 Non-reactive for any FDA-listed relevant communicable disease agent 4.6 Non-reactive for cytomegalovirus (CMV) 4.7 Express blood group O~Exclusion Criteria:~1. Be unwilling or unable to give informed consent~2. Be pregnant~3. Have a prior history of: (i) a bone marrow transplant, or (ii) cancer of any type

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 61 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).